Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2257 per EA under NDC 65862085430. Its NADAC has been published 479 times since Jun 21, 2017.
FDA first approved this application on May 15, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862085430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206906FDA Approved
5/15/2017
TE Code
AB
On Market Since
5/15/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 479 times since Jun 21, 2017, and over the history we have for it it has declined 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $0.9426 (Aug 16, 2017) |
| All-time low | $0.2257 (Aug 19, 2026) |
| 52-week high | $0.2866 |
| 52-week low | $0.2257 |
| Median price | $0.4112 |
| Average price | $0.4554 |
| Largest weekly change | +64.3% (Jul 21, 2021) |
| Weeks tracked | 479 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Aurobindo Pharma Limited, is $0.2257 per EA (NDC 65862085430), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 74.4%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jun 21, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2257 (Aug 19, 2026) to a high of $0.9426 (Aug 16, 2017), with a median of $0.4112 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 65862085430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.